FMP
NASDAQ
72.75 USD
1.48 (2.03%)
Mr. Todd C. Davis Ph.D.
Healthcare
Biotechnology
https://www.ligand.com
NASDAQ
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by Streptococcus pneumoniae; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic...
0000886163
US53220K5048
53220K504
5980 Horton Street
858 550 7500
US
58
Nov 18, 1992
0000886163
NASDAQ
Biotechnology
Healthcare
53220K504
US53220K5048
US
72.75
0.93
157.5k
1.29B
-
49.24-94.57
28.31
-
-
-
-
24.01
-
https://www.ligand.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.